(19)
(11) EP 3 037 524 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.03.2020 Bulletin 2020/10

(45) Mention of the grant of the patent:
11.12.2019 Bulletin 2019/50

(21) Application number: 14838289.8

(22) Date of filing: 22.08.2014
(51) International Patent Classification (IPC): 
C12N 5/079(2010.01)
A61L 27/00(2006.01)
C12Q 1/02(2006.01)
G01N 33/50(2006.01)
 A61K 35/44(2015.01)
A61P 27/02(2006.01)
G01N 33/15(2006.01)
(86) International application number:
PCT/JP2014/072065
(87) International publication number:
WO 2015/025967 (26.02.2015 Gazette 2015/08)

(54)

METHOD FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELLS

VERFAHREN ZUR HERSTELLUNG VON NETZHAUTGEWEBE UND RETINAVERWANDTEN ZELLEN

PROCÉDÉ DE PRODUCTION DE TISSU RÉTINIEN ET DE CELLULES ASSOCIÉES À LA RÉTINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 23.08.2013 JP 2013173285

(43) Date of publication of application:
29.06.2016 Bulletin 2016/26

(60) Divisional application:
19212683.7

(73) Proprietors:
  • Sumitomo Chemical Company, Limited
    Tokyo 104-8260 (JP)
  • RIKEN
    Wako-shi, Saitama 351-0198 (JP)

(72) Inventors:
  • NAKANO, Tokushige
    Osaka-shi Osaka 554-8558 (JP)
  • OZONE, Chikafumi
    Wako-shi Saitama 351-0198 (JP)
  • SASAI, Yoshiki
    deceased (JP)

(74) Representative: J A Kemp LLP 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)


(56) References cited: : 
WO-A1-2006/053629
WO-A1-2013/077425
 WO-A1-2011/055855
WO-A2-2011/043591
   
  • La Torre A et al.: "16. Production and transplantation of retinal cells from human and mouse embryonic stem cells" In: Wang S-Z (ed.): "Retinal Development: Methods and Protocols. Methods in Molecular Biology, vol. 884.", 12 May 2012 (2012-05-12), Humana Press, US, XP008183820, ISBN: 978-1-61779-847-4 pages 229-246, [retrieved on 2012-05-10] * paragraph [02.2] - paragraph [02.4] *
  • WATANABE K. ET AL.: 'Directed differentiation of telencephalic precursors from embryonic stem cells' NATURE NEUROSCIENCE vol. 8, no. 3, 2005, pages 288 - 296, XP002487263
  • HANAKO IKEDA ET AL.: 'Kansaibo no Kisoteki Kenkyu Dai 2 Sho Kansaibo no Unmei o Kaeru Shikumi 2. ES Saibo o Mochiita Shikenkan-nai deno Shinkei Bunka Yudo - Shuno Zenku Saibo to Shinkei Momaku Zenku Saibo' EXPERIMENTAL MEDICINE vol. 24, no. 2, 2006, pages 188 - 194, XP008182863
  • OSAKADA F. ET AL.: 'Control of neural differentiation from pluripotent stem cells' INFLAMM REGEN vol. 28, no. 3, 2008, pages 166 - 173, XP055321518
  • LAMBA D.A. ET AL.: 'Efficient generation of retinal progenitor cells from human embryonic stem cells' PNAS vol. 103, no. 34, 2006, pages 12769 - 12774, XP008155440
  • LANG R.A. ET AL.: 'Pathways regulating lens induction in the mouse' INT. J. DEV. BIOL. vol. 48, 2004, pages 783 - 791, XP055321537
  • FURUTA Y. ET AL.: 'BMP4 is essential for lens induction in the mouse embryo' GENES DEV. vol. 12, no. 23, 1998, pages 3764 - 3775, XP055006571
  • TROUSSE F. ET AL.: 'Bmp4 mediates apoptotic cell death in the developing chick eye' J NEUROSCI. vol. 21, no. 4, 2001, pages 1292 - 1301, XP055321540
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).